ADMA Biologics Acquired Biotest?s Therapy Business To Follow Their Expansion PlaPosted by sainath on January 7th, 2019 The biologics market size is expected to grow around USD320 billion by 2021 growing at double digit compound annual growth rate (CAGR). The growth in the biologics market is mainly due to government initiatives for the research and development of biopharmaceutical drugs, increasing healthcare access among developing and underdeveloped nations, and rising mergers and acquisitions in the biologics market. Major trends witnessed in the biologics market over the historic period include increasing demand for biologics in the treatment of complex diseases, rising development of next generation biologics and revised FDA regulations facilitating biologics drug development. Download Sample Report On Biologics Market At https://www.thebusinessresearchcompany.com/sample.aspx?id=1831&type=smp The major mergers and acquisition in market has helped the big pharma companies to overcome the obstacles in R&D productivity. As a result, currently the pipelines of major companies like AstraZeneca, Sanofi have biological drugs, constituting nearly 30-40%, in the clinical stage. ADMA Biologics, Inc. acquired Therapy Business of Biotest Pharmaceuticals Corporation, a 50% minus one share of ADMA. The deal includes two U.S. Food and Drug Administration (FDA) licensed products, Nabi-HB (Hepatitis B Immune Globulin, Human) and BIVIGAM (Immune Globulin Intravenous, Human), manufacturing and testing operations with two facilities in Boca Raton, Florida. ADMA also received USD27.5 million in cash of which USD15.0 million is in the form of a loan from Biotest Pharmaceuticals Corporation. Order Biologics Market Report At https://www.thebusinessresearchcompany.com/report/biologics-market About The Business Research Company The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally. Contact Information. The Business Research Company Europe: +44 207 1930 708 Asia: +91 8897263534 Americas: +1 315 623 0293 Email: info@tbrc.info Like it? Share it! More by this author |